Ophthalmology

Top Story

VIDEO: Connectomics used to aggregate data on effects of low vision on visual pathways

May 4, 2016

SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, James Weiland, MD, of the USC Roski Eye Institute, describes connectomics in low vision, a new area of research that incorporates detailed study of structure and function of the retina and of the brain to determine the effect of low vision and blindness on visual pathways.

Meeting News CoverageVideo

VIDEO: LADDER trial underway to compare long-term port delivery of ranibizumab with monthly injections

May 3, 2016
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Jill Hopkins, MD, medical director at Genentech, describes the company's LADDER trial, an…
Meeting News CoverageVideo

VIDEO: Clinical trials show similarities between ranibizumab, aflibercept in treating DME

May 3, 2016
SEATTLE — At the Association for Research in Vision and Ophthalmology meeting, Marco A. Zarbin, MD, PhD, discusses a review of randomized clinical trials of anti-VEGF…
Meeting News Coverage

Abnormal ERGs reversed to normal in patients treated with Jetrea

May 3, 2016
SEATTLE — Full-field electroretinograms in patients treated with ocriplasmin changed normally, and treated patients with abnormal ERGs reversed to normal by 2…
Meeting News Coverage

CooperVision studies myopia control using daily disposables in children

May 3, 2016
SEATTLE – “With every diopter of increase in myopia, you have an increased risk of ocular pathology,” according to Arthur Back, BOptom, PhD
More News Headlines »
Original Article

Corneal Stromal Demarcation Line Depth Following Standard and a Modified High Intensity Corneal Cross-linking Protocol

Journal of Refractive Surgery, April 2016, Volume 32 Issue 4
To compare the corneal stromal demarcation line depth using anterior segment optical coherence tomography (AS-OCT)…
More »
CME

Key Components in the Design and Execution of a Successful Clinical Trial

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ARVO

Highlights from ARVO

Video
Meeting News Coverage

VIDEO: LADDER trial underway to compare long-term port delivery of ranibizumab with monthly injections

May 3, 2016
More »